MindMed Study at Psych Congress 2025 Finds High Suicidal Ideation in Adults with GAD

MindMed Study Highlights Alarmingly High Rates of Suicidal Ideation in Adults with Generalized Anxiety Disorder Researchers from Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), a late-stage clinical biopharmaceutical company pioneering innovative therapies for brain health disorders, have unveiled concerning findings from…

Read MoreMindMed Study at Psych Congress 2025 Finds High Suicidal Ideation in Adults with GAD

Asia-Pacific Neuro-Navigation Systems Market 2025-2035: Competitive Insights on Saphirex, SURGLASSES & HRS

Asia-Pacific Stereotactic Neuro-Navigation System Market Outlook 2025-2035: Trends, Drivers, Challenges, and Competitive Landscape The Asia-Pacific (APAC) stereotactic neuro-navigation system market is poised for significant expansion over the next decade. According to current projections, the market is expected to reach approximately…

Read MoreAsia-Pacific Neuro-Navigation Systems Market 2025-2035: Competitive Insights on Saphirex, SURGLASSES & HRS
NYU Abu Dhabi

Tanner Health, Healthliant Ventures Partner with Incision USA on OR Innovations

Tanner Health and Healthliant Ventures Join Forces with Incision USA to Transform Surgical Team Performance with Digital OR Solutions Tanner Health and Healthliant Ventures have announced a new partnership with Incision USA, a healthcare technology company specializing in solutions that…

Read MoreTanner Health, Healthliant Ventures Partner with Incision USA on OR Innovations

EC Approves Henlius and Organon’s Denosumab Biosimilars BILDYOS® and BILPREVDA®

European Commission Approves Henlius and Organon’s Denosumab Biosimilars BILDYOS® and BILPREVDA® for All Indications of Reference Medicines The European Commission (EC) has granted marketing authorization to Shanghai Henlius Biotech, Inc. (2696.HK) and Organon (NYSE: OGN) for two denosumab biosimilars, BILDYOS®…

Read MoreEC Approves Henlius and Organon’s Denosumab Biosimilars BILDYOS® and BILPREVDA®

HealthEdge Named to TIME’s 2025 List of the World’s Leading HealthTech Companies

HealthEdge Earns Spot on TIME’s 2025 List of the World’s Top HealthTech Companies HealthEdge® has been named to TIME and Statista’s inaugural list of the World’s Top HealthTech Companies 2025, earning recognition as one of only 400 organizations globally honored…

Read MoreHealthEdge Named to TIME’s 2025 List of the World’s Leading HealthTech Companies

Health & Wellness Market 2025: Preventive Care Trends and Tech-Driven Growth Forecast to 2033

Health and Wellness Market Outlook 2025–2033: Preventive Care, Digital Innovation, and Lifestyle Trends Driving Global Growth The global health and wellness market is entering a transformative decade, poised to grow from US$ 3.52 trillion in 2024 to US$ 4.81 trillion…

Read MoreHealth & Wellness Market 2025: Preventive Care Trends and Tech-Driven Growth Forecast to 2033